首页|期刊导航|中国兽医杂志|以鱼藤酮为例分析细胞活力检测法在抗病毒药物评估中的局限性

以鱼藤酮为例分析细胞活力检测法在抗病毒药物评估中的局限性OA

Analysis of the Limitations of Cell Viability Assays in Antiviral Drug Evaluation Using Rotenone as a Model

中文摘要英文摘要

为揭示常规细胞活力检测方法在抗病毒药物筛选中的局限性,避免因将亚致死性细胞毒性误判为药物安全而影响对药物抗病毒效果的客观评价,本试验以线粒体呼吸链复合物I抑制剂鱼藤酮为模型,利用基于HiBiT标记的重组猪繁殖与呼吸综合征病毒(PRRSV)毒株测定鱼藤酮的抗病毒活性,结合细胞计数试剂盒-8(CCK-8)法和乳酸脱氢酶(LDH)释放法测定其对非洲绿猴胚胎肾细胞系MARC-145的毒性,同时通过明场显微镜观察细胞形态学变化,并对鱼藤酮处理组(10 μmol/L)、PRRSV感染组[接种感染复数(MOI)为0.1的高致病性PRRSV(HP-PRRSV)JXwn06毒株]和鱼藤酮联合感染组(接种MOI为0.1的JXwn06毒株+10 μmol/L鱼藤酮)进行转录组测序,分析差异表达基因和富集通路.结果显示,鱼藤酮抗PRRSV的半数抑制浓度(IC50)为0.082 μmol/L;CCK-8法和LDH法测定的半数细胞毒性浓度(CC50)分别为119.71和114.75 μmol/L,选择指数(SI)达1 399,呈现"低毒高效"特征.明场显微镜观察结果显示,仅10 μmol/L浓度的鱼藤酮即可导致细胞出现明显的变圆肿胀、胞质空泡化和合胞体形成,提示细胞处于强烈应激状态.转录组测序分析显示,单纯鱼藤酮处理显著上调内质网应激标志物DNA损伤诱导转录物3(DDIT3)、细胞周期抑制因子细胞周期蛋白依赖性激酶抑制因子1A(CDKN1A)和溶酶体相关基因组织蛋白酶L(CTSL)的表达,通路富集于凋亡过程的正向调控和对外源性物质刺激的响应;而在PRRSV感染背景下,鱼藤酮联合处理显著下调DNA复制核心因子增殖细胞核抗原(PCNA)和微染色体维持10复制起始因子(MCM10)基因的表达,显著抑制细胞周期相关通路.结果表明,鱼藤酮表现出的"抗病毒表型"实质是宿主细胞生理功能崩溃和增殖抑制后的伴随效应,提示药物筛选中潜在的假阳性风险.常规细胞毒性检测方法的靶点与药物真实毒性机制的错位,可导致假性低毒结果,因此,抗病毒药物安全性的初步评价需整合形态学观察和多维度生理学指标.

To reveal the limitations of conventional cell viability assays in antiviral drug screening and avoid misinterpreting sublethal cytotoxicity as drug safety,thereby affecting the objective evaluation of antiviral efficacy,rotenone,an inhibitor of mitochondrial respiratory chain complex I,was used as a model compound in this study.The antiviral activity of rotenone was evaluated using a recombinant porcine reproductive and respiratory syndrome virus(PRRSV)strain carrying a HiBiT tag.The cytotoxicity of rotenone to African green monkey embryonic kidney cells(MARC-145)was assessed using the cell counting kit-8(CCK-8)assay and lactate dehydrogenase(LDH)release assay.Cellular morphological changes were observed by bright-field microscopy.Furthermore,transcriptome sequencing was performed on rotenone-treated cells(10 μmol/L),PRRSV-infected cells[infected with highly pathogenic PRRSV(HP-PRRSV)strain JXwn06 at a multiplicity of infection(MOI)of 0.1],and rotenone-treated PRRSV-infected cells(infected with JXwn06 at an MOI of 0.1 and treated with 10 μmol/L rotenone)to analyze differentially expressed genes and enriched pathways.The results showed that rotenone exhibited anti-PRRSV activity with a half-maximal inhibitory concentration(IC50)of 0.082 μmol/L.The half-maximal cytotoxic concentrations(CC50)determined by the CCK-8 and LDH assays were 119.71 and 114.75 μmol/L,respectively,resulting in a selectivity index(SI)of 1 399,indicating an apparent"low toxicity and high efficacy"profile.However,bright-field microscopy revealed that rotenone at a concentration of only 10 μmol/L induced obvious cellular abnormalities,including cell rounding,swelling,cytoplasmic vacuolization,and syncytium formation,suggesting severe cellular stress.Transcriptomic analysis showed that rotenone treatment alone significantly upregulated the expression of endoplasmic reticulum stress marker DNA damage-inducible transcript 3(DDIT3),cell cycle inhibitor cyclin-dependent kinase inhibitor 1A(CDKN1A),and lysosome-associated gene cathepsin L(CTSL).These differentially expressed genes were mainly enriched in pathways related to positive regulation of apoptotic processes and responses to external stimuli.In the context of PRRSV infection,rotenone co-treatment significantly downregulated the expression of DNA replication-associated genes proliferating cell nuclear antigen(PCNA)and minichromosome maintenance 10 replication initiation factor(MCM10),resulting in marked inhibition of cell cycle-related pathways.These results indicate that the apparent"antiviral phenotype"induced by rotenone is essentially an accompanying effect of host cell physiological dysfunction and proliferation inhibition,highlighting the potential risk of false-positive results in antiviral drug screening.The mismatch between the targets of conventional cytotoxicity assays and the actual mechanisms underlying drug toxicity may lead to falsely favorable safety evaluations.Therefore,preliminary safety assessment of antiviral candidates should integrate morphological observations with multidimensional physiological indicators.

刘天娇;杨汉春;刘瑞;周琼琼;高鹏;张永宁;盖新娜;韩军;郭鑫;周磊

中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193中国农业大学动物医学院 兽医公共卫生安全全国重点实验室,北京 海淀 100193

农业科技

鱼藤酮猪繁殖与呼吸综合征病毒(PRRSV)抗病毒药物筛选细胞毒性评价转录组测序CCK-8局限性

rotenoneporcine reproductive and respiratory syndrome virus(PRRSV)antiviral drug screeningcytotoxicity evaluationtranscriptome sequencinglimitations of CCK-8 assay

《中国兽医杂志》 2026 (9)

38-46,9

"十四五"国家重点研发计划(2023YFD1800801)国家现代农业产业技术体系(CARS-35)

10.20157/j.cnki.zgsyzz.2026.sf.067

评论